Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review study.
暂无分享，去创建一个
Keunchil Park | O. Arrieta | E. Swallow | J. Cadranel | M. Pless | Jie Zhang | K. Stein | D. Patel | P. Galebach | E. Bendaly | A. Kageleiry | R. Degun | A. Nosal | M. Sasane